Reaction

Transplant Failure reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,407 reports · 79 co-occurring drugs

As of the last recalculation, Transplant Failure appears in 2,407 FAERS reports alongside 79 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 137.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Busulfan	226	137.0	139.0
Anti-Thymocyte Globulin (Rabbit)	99	110.6	112.0
Fludarabine Phosphate	375	97.5	98.4
Thiotepa	99	93.4	94.4
Basiliximab	107	82.3	83.0
Alemtuzumab	164	78.6	79.3
Tacrolimus	880	76.0	76.4
Tacrolimus Ointment 0.1%	719	70.8	71.2
Tacrolimus Extended-Release Capsules	720	70.7	71.1
Sirolimus	103	69.0	69.5
Mycophenolate Mofetil	744	68.1	68.5
Mycophenolate Mofetil Hydrochloride	744	68.0	68.4
Mycophenilic Acid	91	39.4	39.6
Ganciclovir Sodium	45	37.5	37.6
Melphalan	94	37.1	37.3
Melphalan Hydrochloride	103	37.1	37.2
Ganciclovir	43	37.0	37.1
Mycophenolic Acid	129	36.8	36.9
Valganciclovir	76	36.0	36.1
Valganciclovir Hydrochloride	76	36.0	36.1
Valganciclovir Hydrochloride Powder,	49	35.4	35.6
Cyclosporine	302	26.7	26.8
Cefuroxime	34	26.1	26.1
Dextrose	35	23.3	23.4
Eplerenone	34	23.3	23.3
Dextrose Monohydrate	35	23.0	23.0
Cyclophosphamide Injection, Solution	346	19.6	19.6
Cyclophosphamide	346	19.6	19.6
Cyclophosphamide For Injection	346	19.6	19.6
Micafungin Sodium	19	19.5	19.6
Amphotericin B	27	18.8	18.9
Blinatumomab	21	17.5	17.6
Filgrastim	69	16.3	16.3
Anakinra	30	15.8	15.9
Prednisolone	260	13.8	13.9
Prednisolone Oral	260	13.8	13.9
Prednisolone Oral Solution	260	13.8	13.9
Mesna Injection	13	13.7	13.7
Mesna	13	13.4	13.4
Sennosides 8.6 Mg Tablets	32	13.4	13.4
Senna	32	13.3	13.3
Senna Leaf	34	12.9	12.9
Hydroxyurea	30	12.4	12.4
Prednisolone Acetate	13	10.9	10.9
Methylprednisolone	157	10.4	10.4
Everolimus Tablets	20	10.4	10.4
Epoetin Alfa	14	10.3	10.3
Sennosides	35	10.3	10.3
Abacavir Sulfate	11	9.8	9.8
Itraconazole	13	9.7	9.7
Voriconazole Injection	24	9.6	9.7
Agalsidase Beta	10	9.4	9.4
Clarithromycin	35	8.9	8.9
Eculizumab	54	8.8	8.8
Posaconazole Delayed-Release	11	8.7	8.7
Efavirenz	11	8.6	8.6
Voriconazole	29	8.3	8.4
Azathioprine	80	8.1	8.1
Ursosiol	17	7.6	7.6
Posaconazole	13	7.0	7.0
Heparin Sodium	11	6.9	6.9
Ursodiol	17	6.8	6.8
Eltrombopag Olamine	16	6.0	6.0
Meropenem	22	6.0	6.0
Darbepoetin Alfa	36	5.8	5.9
Cytarabine	40	5.8	5.8
Rituximab	133	5.7	5.7
Cefepime	9	5.4	5.4
Etoposide	44	5.3	5.3
Imatinib	10	4.9	4.9
Azacitidine For	10	4.8	4.8
Axicabtagene Ciloleucel	5	4.4	4.4
Doxorubicin Hydrochloride	16	4.3	4.3
Ribavirin	31	4.2	4.2
Azacitidine	13	3.8	3.8
Ruxolitinib	29	3.5	3.5
Paricalcitol	5	3.1	3.1
Cinacalcet Hydrochloride	12	2.2	2.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	6	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.